GPNMB c.1217G>C ;(p.G406A)

Variant ID: 7-23307604-G-C

NM_002510.2(GPNMB):c.1217G>C;(p.G406A)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.

Plos Medicine
Goh, Gerald G; Schmid, Ramona R; Guiver, Kelly K; Arpornwirat, Wichit W; Chitapanarux, Imjai I; Ganju, Vinod V; Im, Seock-Ah SA; Kim, Sung-Bae SB; Dechaphunkul, Arunee A; Maneechavakajorn, Jedzada J; Spector, Neil N; Yau, Thomas T; Afrit, Mehdi M; Ahmed, Slim Ben SB; Johnston, Stephen R SR; Gibson, Neil N; Uttenreuther-Fischer, Martina M; Herrero, Javier J; Swanton, Charles C
Publication Date: 2016-12

Variant appearance in text: GPNMB: G406A
PubMed Link: 27923043
Variant Present in the following documents:
  • pmed.1002136.s018.xlsx, sheet 1
  • pmed.1002136.s022.xlsx, sheet 1
View BVdb publication page